# Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response

> **NCT04351126** · PHASE2 · COMPLETED · sponsor: **Ganin Fertility Center** · enrollment: 107 (actual)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** Fludrocortisone 0.1 Milligrams (mg)
- **DRUG:** Bromocriptine

## Key facts

- **NCT ID:** NCT04351126
- **Lead sponsor:** Ganin Fertility Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-02-29
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2020-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04351126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04351126, "Management of Ovarian Hyperstimulation Syndrome as a State of Defective Mineralocorticoid Response". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04351126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*